13D Filing: Ardsley Partners and Marrone Bio Innovations Inc (MBII)

CUSIP No. 053761102

13D

Page 11 of 14 Pages

 

The
General Partner may be deemed, for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, to be the beneficial
owner of an aggregate as of 15,631,580 shares of Common Stock as of February 5, 2017, which represent 14.56% of the Issuer’s
outstanding shares of Common Stock.

 

(i)
Sole power to vote or direct vote: 0

(ii)
Shared power to vote or direct vote: 15,631,580

(iii)
Sole power to dispose of or direct the disposition: 0

(iv)
Shared power to dispose of or direct the disposition: 15,631,580

 

The
Renewable Energy Fund may be deemed, for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, to be the
beneficial owner of an aggregate of 13,846,580 shares of Common Stock as of February 5, 2017, which represent 12.90% of the Issuer’s
outstanding shares of Common Stock.

 

(i)
Sole power to vote or direct vote: 0

(ii)
Shared power to vote or direct vote: 13,846,580

(iii)
Sole power to dispose of or direct the disposition: 0

(iv)
Shared power to dispose of or direct the disposition: 13,846,580

 

The
Fund II may be deemed, for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, to be the beneficial
owner of an aggregate of 595,300 shares of Common Stock as of February 5, 2018, which represent 0.58% of the Issuer’s outstanding
shares of Common Stock.

 

(i)
Sole power to vote or direct vote: 0

(ii)
Shared power to vote or direct vote: 595,300

(iii)
Sole power to dispose of or direct the disposition: 0

(iv)
Shared power to dispose of or direct the disposition: 595,300

 

The
Advanced Healthcare Fund may be deemed, for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, to be
the beneficial owner of an aggregate of 1,189,700 shares of Common Stock as of February 5, 2018, which represent 1.17% of the
Issuer’s outstanding shares of Common Stock.

 

(i)
Sole power to vote or direct vote: 0

(ii)
Shared power to vote or direct vote: 1,189,700

(iii)
Sole power to dispose of or direct the disposition: 0

(iv)
Shared power to dispose of or direct the disposition: 1,189,700

 

The
Duckdive Fund may be deemed, for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, to be the beneficial
owner of an aggregate of 50,000 shares of Common Stock as of February 5, 2018, which represent 0.05% of the Issuer’s outstanding
shares of Common Stock.

 

(i)
Sole power to vote or direct vote: 0

(ii)
Shared power to vote or direct vote: 50,000

(iii)
Sole power to dispose of or direct the disposition: 0

(iv)
Shared power to dispose of or direct the disposition: 50,000